Canada
Application follows successful pre-clinical animal studies at the University of Arkansas
Hi, what are you looking for?
Mugglehead Investment Magazine
Canada
Canada
Novel proprietary psychedelic molecule continues to demonstrate potential for treating cocaine dependency
Business
The company also released 7 new products under its Tilray and Aphria brands
Canada
Rise & Shine CBD Drops will initially be available in British Columbia followed by national distribution this fall
Canada
Cannabinoid tablet supplier expands its Canadian distribution network
Canada
Biotechnology organization will also supply LaNeo product to Australian research institute for clinical trial
Business
Tilray's products are now approved by the Polish Ministry of Health
Business
The partnership started in 2018
Business
The company said there was a significant downturn in the California and Oregon markets
Business
Company still expects to observe revenue growth for the remainder of 2022
